A randomized, double-blind, placebo-controlled clinical trial of Bupropion for the prevention of smoking in youth with attention-deifcit/hyperactivity disorder
A randomized, double-blind, placebo-controlled clinical trial of Bupropion for the prevention of smoking in youth with attention-deifcit/hyperactivity disorder. Proceedings of the NCI Tobacco Control Investigator's Meeting: Synthesizing Research for the Public's Health. 2004.